News | March 10, 2009

Abbott Launches VOYAGER NC Coronary Balloon Catheter


March 10, 2009 - Abbott today launched the VOYAGER NC Coronary Dilatation Catheter, a next-generation balloon dilatation catheter with high-pressure capability designed to optimize the treatment of patients with coronary artery disease (CAD) during angioplasty procedures.

VOYAGER NC is now available in the U.S., Europe and select countries in Asia and Latin America.

The new VOYAGER NC system can be used for both pre-dilatation and post-dilatation procedures. Physicians can use VOYAGER NC to navigate tortuous anatomy and open up lesions before a stent is delivered, or expand a stent more precisely against the vessel wall after it is implanted.

The VOYAGER NC is available in a wide variety of diameters (from 2 mm to 5 mm) and lengths (from 6 mm to 25 mm) on a rapid exchange delivery system.

"When choosing a dilatation catheter, one of the key attributes interventional cardiologists look for is the ability to accurately deliver the balloon to the target lesion, particularly in challenging coronary anatomy," said Dean J. Kereiakes, M.D., medical director, The Christ Hospital Heart and Vascular Center in Cincinnati, OH. "VOYAGER NC delivers on its promise as a high performance balloon dilatation catheter with high-pressure capability, frequently making difficult cases easier, even when treating the most challenging lesions."

Proprietary technological advancements that Abbott engineered into the VOYAGER NC balloon dilatation catheter include:

• A specialized tip with a smooth, rounded shape designed to deflect off stent struts and enhance balloon delivery through stents.

• Flexible tungsten markers designed to help physicians navigate through arteries and properly position the balloon within a treatment area.

• Bi-layer balloon material designed to make the balloon thinner and more flexible, enabling controlled balloon growth.

For more information: www.abbott.com


Related Content

News | Balloon Catheter

June 13, 2024 — The U.S. Food and Drug Administration (FDA) announced that Teleflex, and their subsidiary Arrow ...

Home June 13, 2024
Home
News | Balloon Catheter

April 4, 2024 — The U.S. Food and Drug Administration (FDA) announced that Medos International Sàrl is recalling ...

Home April 04, 2024
Home
News | Balloon Catheter

January 18, 2024 — Summa Therapeutics, LLC announced that the first-in-man injectable angioplasty procedures for ...

Home January 18, 2024
Home
News | Balloon Catheter
Cardiovascular Systems, Inc., a medical device company developing and commercializing innovative interventional ...
Home February 25, 2022
Home
News | Balloon Catheter

February 15, 2022 – CERENOVUS, an emerging leader in neurovascular care and part of Johnson & Johnson Medical Devices ...

Home February 15, 2022
Home
News | Balloon Catheter

May 20, 2021 — Boston Scientific Corporation announced it has initiated the AGENT IDE trial for the Agent Drug-Coated ...

Home May 20, 2021
Home
Feature | Balloon Catheter | By Dave Fornell, Editor

The first devices developed for interventional cardiology were percutaneous transluminal coronary angioplasty (PTCA) ...

Home March 16, 2021
Home
Feature | Balloon Catheter

February 17, 2021 — The U.S. Food and Drug Administration (FDA) has cleared Shockwave Medical's Intravascular ...

Home February 17, 2021
Home
News | Balloon Catheter

June 4, 2020 — Transit Scientific announced the U.S. Food and Drug Administration (FDA) cleared the XO Score ...

Home June 04, 2020
Home
News | Balloon Catheter

February 24, 2020 — Abbott has voluntarily recalled specific lots of two types of its coronary angioplasty catheters — ...

Home February 24, 2020
Home
Subscribe Now